|
1. Dacey M, Baltzell A, Zaichkowsky LJAjohb. Older adults' intrinsic and extrinsic motivation toward physical activity. 2008;32(6):570-82. doi: 10.5555/ajhb.2008.32.6.570 2. Arazi H, Hosseini RJJoGUoMS. The prevalence of anabolic-androgenic steroids abuse, knowledge and attitue of their side effects, and attitude toward them among the bodybuilding athletes in Rasht. 2011;20(80):34-41. (Persian) 3. Pedersen W, Wichstrøm L, Blekesaune MJJoiv. Violent behaviors, violent victimization, and doping agents: A normal population study of adolescents. 2001; 16(8):808-32. doi.org/10.1177/088626001016008005 4. Peters MA, Phelps LJPitS. Body image dissatisfaction and distortion, steroid use, and sex differences in college age bodybuilders. 2001;38(3):283-9. doi.org/10.1002/pits.1018 5. Lundholm L, Käll K, Wallin S, Thiblin IJD, dependence a. Use of anabolic androgenic steroids in substance abusers arrested for crime. 2010;111(3):doi.org/10.1016/j.drugalcdep.2010.04.020 6. Achar S, Rostamian A, Narayan SMJTAjoc. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. 2010; 15;106(6):893-901. doi: 10.1016/j.amjcard.2010.05.013 7. Street C, Antonio J, Cudlipp DJCJoAP. Androgen use by athletes: a reevaluation of the health risks. 1996;21(6):421-40. doi.org/10.1139/h96-038 8. Kargarfard M, GHIAS M, KarimZadegan A, Kashi A. Assumption of anabolic-androgenic steroids among Isfahan University students: prevalence, and awareness about their side effects. 2006; 12(2):12-20. doi 10.22038/JFMH.2006.1805 9. Katzung BG. Basic and clinical pharmacology: McGraw-Hill Education; 2017; 3(2):33-40. doi.org/10.2344/0003-3006-60.1.25 10. Jean D. Androgens in, Goodman Gilman A; Rall TW, Nies AS. Goodman and Gilman‘s the pharmacological basis of Therapeutics. pergamon press, USA; 1991; 14(3):24-29. doi.org/10.1001/jama.1997.03550060100050 11. Perry PJ, Andersen KH, Yates WRJTAjosm. Illicit anabolic steroid use in athletes: a case series analysis. 1990;18(4):422-8.doi.org/10.1177%2F036354659001800416 12. Naghdi H, Mohammadi SJJoKUoMS. Prevalence and awareness of the side effects of anabolic steroid use among school students in Kurdistan, 2012. 2013;17(3):206-9. (Persian) 13. Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Perez C, Hernandez J, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. 2005;39(5): 27-33.doi.org/10.1136/bjsm.2004.013599 14. Kristiansen M, Levy-Milne R, Barr S, Flint AJIJoSN, Metabolism E. Dietary supplement use by varsity athletes at a Canadian university. 2005;15(2):195-210. doi.org/10.1123/ijsnem.15.2.195 15. Nojoomi M, Behravan V. Study of anabolic steroids and the awareness of their complications in bodybuilding athletes in Karaj (2003). Razi Journal of Medical Sciences. 2005;11(44):1057-63. (Persian) 16. Kashi A, Kargarfard M, Moulavi H. Ergogenic substance in body building athletes: prevalence, cognitive and awareness of about their side effects. 2006;2(1):13-20. (Persian) 17. Arazi H, Hosseini R. The prevalence of anabolic-androgenic steroids abuse, knowledge and attitue of their side effects, and attitude toward them among the bodybuilding athletes in Rasht. Journal of Guilan University of Medical Sciences. 2011;20(80):34-41. (Persian) 18. Eskandarion M, Kheirvari Khezerloo J, Hemmatian S, Tabasi M, Ghorbani R. Prevalence of Anabolic Steroids among the Male Bodybuilding Athletes and Rate of Awareness to Side Effects in Shahrud. Iranian Journal of Forensic Medicine. 2019;25(1):1-7. (Persian) 19. Naqvi SY, Flaherty G. Knowledge, and Attitudes of Amateur Sports Participants Regarding the Cardiac Risks Associated with the Use of Anabolic-Androgenic Steroids. IOSR Journal of Sports and Physical Education. 2016:36-44. doi.org/10.9790/6737-03033644 20. Laure P, Lecerf T, Friser A, Binsinger CJIjosm. Drugs, recreational drug use and attitudes towards doping of high school athletes. 2004;25(02):133-8. doi.org/10.1055/s-2004-819946 21. Green GA, Uryasz FD, Petr TA, Bray CDJCjosm. NCAA study of substance use and abuse habits of college student-athletes. 2001;11(1):51-6. doi.org/10.1097/00042752-200101000-00009 22. Evans NA. Current concepts in anabolic-androgenic steroids. The American Journal of Sports Medicine. 2004;32(2):534-42. doi.org/1177/0363546503262202 23. Laure P, Binsinger C. Doping prevalence among preadolescent athletes: a 4-year follow-up. British journal of sports medicine. 2007;41(10):660-3. doi.org/10.1136/bjsm.2007.035733 24. Mobasheri A, Proudman CJ. Cobalt chloride doping in racehorses: Concerns over a potentially lethal practice. The Veterinary Journal. 2015;205(3):335-8. doi.org/10.1016/j.tvjl.2015.04.005 25. McNamee MJ. The spirit of sport and the medicalisation of anti-doping: empirical and normative ethics. Asian bioethics review. 2012; 4(4):374-92. doi.org/10.4324/9781003075004-22 26. Node K, Michishita R, Tsuruta T, Shono N, Inoue T. Effect of exercise therapy on monocyte and neutrophil counts in overweight women. The American journal of the medical sciences. 2010;339(2):152-6. doi.org/10.1097/maj.0b013e3181c6a980 27. Jabari M, Al-shehri H, Al-faris A, Al-sayed M, Algaeed F, Al-sobaie N, et al. The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia). Electronic physician. 2016;8(12):3343. doi.org/10.19082/3343 28. Fayyazi Bordbar MR, Abdollahian E, Samadi R, Dolatabadi H. Frequency of use, awareness, and attitudes toward side effects of anabolic–androgenic steroids consumption among male medical students in Iran. Substance use & misuse. 2014;49(13):1751-8. doi.org/10.3109/10826084.2014.880175 29. Arazi H, Salehi A. Attitude and Awareness of Male Bodybuilders Toward Adverse Effects of Anabolic-androgenic Steroids in Qazvin, Iran. Iranian Journal of Epidemiology. 2014;9(3):45-53. (Persian) 30. Robles‐Diaz M, Gonzalez‐Jimenez A, Medina‐Caliz I, Stephens C, García‐Cortes M, García‐Muñoz B, et al. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Alimentary pharmacology & therapeutics. 2015;41(1):116-25. doi.org/10.1111/apt.13023
|
